U.S. Senator Elizabeth Warren (D-MA) publicly condemned the Department of Justice's decision to allow UnitedHealth to acquire home health and hospice giant Amedisys for $3.3 billion. In a post on X on Sunday, November 1, 2026, Senator Warren stated that UnitedHealth already "sells your insurance, employs your doctor, and manages your prescriptions." She warned that the acquisition would give the company "MORE power to raise costs and deny care," concluding with a direct call to action: "We need to break up Big Medicine."
The healthcare sector has recently seen significant consolidation, attracting scrutiny from regulators and consumer advocates concerned about potential impacts on pricing and service access. The $3.3 billion acquisition of Amedisys by UnitedHealth integrates a major home health and hospice provider into one of the largest healthcare conglomerates. This specific deal, approved by the DOJ, follows a period of increased examination of large mergers across various industries, particularly those with direct consumer effects, as highlighted in numerous reports on market concentration.
Senator Warren's statement implies that the ongoing consolidation of healthcare providers and insurers leads to reduced competition and potentially higher costs for consumers. Her call to "break up Big Medicine" signals a potential legislative or regulatory push for stronger antitrust enforcement within the healthcare industry. This position indicates that policymakers like Warren will continue to scrutinize large healthcare mergers and could advocate for interventions to address market concentration and its effects on affordability and access to care.
